Luxna Biotech Co., Ltd. is pleased to announce that it has entered into a collaboration with BioSpring GmbH (Headquarters: Frankfurt, Germany), a global leader in the manufacturing of therapeutic oligonucleotides, leveraging Luxna’s proprietary XNA technology. 

For more details, please click here.